Construction of leptin gene modified tissue engineered composites in vitro

Abstract

Abstract: PURPOSE: To evaluate the feasibility of constructing tissue engineered composites in vitro by combining human leptin (hLEP) gene modified rat bone marrow stromal cells (BMSCs) and guided tissue regeneration collagen membrane (Bio-Gide). METHODS: BMSCs of SD rats were isolated and cultured by whole bone marrow adherent method. BMSCS were transfected with adenovirus carrying hLEP gene (Ad-hLEP-EGFP) and observed under inverted fluorescence microscope. Enzyme linked immunosorbent assay (ELISA) was used to detect the expression of hLEP. The proliferation activity of transfected cells was assessed by MTT assay. Ad-hLEP-EGFP transfected BMSCs were cultured for 24 h in combination with Bio-Gide collagen membrane, hLEP modified tissue engineered composite was observed under laser scanning confocal microscope (LSCM) and scanning electron microscope (SEM). RESULTS: Through Ad-hLEP-EGFP transfection, hLEP was overexpressed in BMSCs, which didn't affect the proliferation of cells. SEM showed hLEP modified BMSCs grew well on Bio-Gide collagen membrane and secreted extracellular matrix. LSCM suggested BMSCs could migrate to different scales of Bio-Gide collagen membrane. CONCLUSIONS: hLEP modified BMSCs can be combined with Bio-Gide collagen membrane and grow well, suggesting that hLEP modified tissue engineered composite can be successfully constructed. The composite might be suitable for periodontal tissue engineering.

Key words: Leptin, Bone marrow stromal cell, Collagen membrane, Adenovirus, Tissue engineering

CLC Number:

R318.01

ZHENG Bao-yu, HE Meng-jiao, JIANG Jun, LUO Kai, CHEN Yu-ling, YAN Fu-hua. Construction of leptin gene modified tissue engineered composites in vitro[J]. Shanghai Journal of Stomatology, 2016, 25(6): 641-646.

References

[1] Cochran DL, Wozney JM. Biological mediators for periodontal regeneration [J]. Periodontol 2000, 1999, 19: 40-58.
[2] Bartold PM, McCulloch CA, Narayanan AS, et al. Tissue engineering: a new paradigm for periodontal regeneration based on molecular and cell biology [J]. Periodontol 2000, 24: 253-269.
[3] Intini G. Future approaches in periodontal regeneration: gene therapy, stem cells, and RNA interference [J]. Dent Clin North Am, 2010, 54(1): 141-155.
[4] 骆凯, 郑宝玉, 陈玉玲, 等. 瘦素基因修饰对大鼠骨髓基质细胞生物学行为的影响 [J]. 口腔医学研究, 2014, 30(9): 818-822.
[5] 江俊, 闫福华, 骆凯, 等. hBMP-7基因瞬时转染绝经后骨质疏松大鼠骨髓基质细胞的表达及对其生物学活性的影响 [J]. 福建医科大学学报, 2011, 45(4): 238-241.
[6] Jiang XQ, Chen JG, Gittens S, et al. The ectopic study of tissue-engineered bone with hBMP-4 gene modified bone marrow stromal cells in rabbits [J]. Chin Med J (Engl), 2005, 118(4): 281-288.
[7] Schek RM, Wilke EN, Hollister SJ, et al. Combined use of designed scaffolds and adenoviral gene therapy for skeletal tissue engineering [J]. Biomaterials, 2006, 27(7): 1160-1166.
[8] 王佃亮. 种子细胞组织工程连载之三[J]. 中国生物工程杂志, 2014, 34(7): 108-113.
[9] 李艳芬, 赵欣, 闫福华, 等. 不同浓度骨髓基质细胞修复大鼠牙周组织缺损的实验研究[J]. 福建医科大学学报, 2010, 44(4): 249-252.
[10] Turgeman G, Pittman DD, Muller R, et al. Engineered human mesenchymal stem cells: a novel platform for skeletal cell mediated gene therapy [J]. J Gene Med, 2001, 3(3): 240-251.
[11] Derubeis AR, Cancedda R. Bone marrow stromal cells (BMSCs) in bone engineering: limitations and recent advances[J]. Ann Biomed Eng, 2004, 32(1): 160-165.
[12] Zhao Z, Wang Z, Ge C, et al. Healing cranial defects with AdRunx2-transduced marrow stromal cells [J]. J Dent Res, 2007, 86(12): 1207-1211.
[13] 张秀丽, 蒋欣泉. 腺病毒介导的骨形成蛋白-2基因修饰促进羊骨髓基质细胞成骨分化的实验研究 [J]. 上海口腔医学, 2006, 15(6): 610-613.
[14] Zhang ZM, Jiang LS, Jiang SD, et al. Osteogenic potential and responsiveness to leptin of mesenchymal stem cells between postmenopausal women with osteoarthritis and osteoporosis [J]. J Orthop Res, 2009, 27(8): 1067-1073.
[15] Johnson RB, Serio FG. Leptin within healthy and diseased human gingiva [J]. J Periodontol, 2001, 72(9): 1254-1257.
[16] Karthikeyan BV, Pradeep AR. Leptin levels in gingival crevicular fluid in periodontal health and disease [J]. J Periodontal Res, 2007, 42(4): 300-304.
[17] Bozkurt FY, Yetkin Ay Z, Sütçü R, et al. Gingival crevicular fluid leptin levels in periodontitis patients with long-term and heavy smoking [J]. J Periodontol, 2006, 77(4): 634-640.
[18] Egermann M, Heil P, Tami A, et al. Influence of defective bone marrow osteogenesis on fracture repair in an experimental model of senile osteoporosis [J]. J Orthop Res, 2010, 28(6): 798-804.
[19] Shimada Y, Komatsu Y, Ikezawa-Suzuki I, et al. The effect of periodontal treatment on serum leptin, interleukin-6, and C-reactive protein [J]. J Periodontol, 2010, 81(8): 1118-1123.
[20] Chen FM, Jin Y. Periodontal tissue engineering and regeneration: current approaches and expanding opportunities[J]. Tissue Eng Part B Rev, 2010, 16(2): 219-255.
[21] Ahmed TA, Dare EV, Hincke M. Fibrin: a versatile scaffold for tissue engineering applications [J]. Tissue Eng Part B Rev, 2008, 14(2): 199-215.
[22] Drury JL, Mooney DJ. Hydrogels for tissue engineering: scaffold design variables and applications [J]. Biomaterials, 2003, 24(24): 4337-4351.
[23] Yang Y, El Haj AJ. Biodegradable scaffolds-delivery systems for cell therapies [J]. Expert Opin Biol Ther, 2006, 6(5): 485-498.
[24] Hall H. Modified fibrin hydrogel matrices: both, 3D-scaffolds and local and controlled release systems to stimulate angiogenesis [J]. Curr Pharm Des, 2007, 13(35): 3597-3607.
[25] 张向荣, 郭光华, 刘德伍, 等. 人骨髓间充质干细胞的分离培养及BrdU标记鉴定[J]. 中国组织工程研究与临床康复, 2009, 13(19): 3618-3622.